Histopathology of Scarring and Nonscarring Hair Loss

    September 2012 in “ Dermatologic Clinics
    John Childs, Leonard C. Sperling
    Image of study
    TLDR The conclusion is that accurate diagnosis of different types of hair loss requires careful examination of tissue samples and understanding of clinical symptoms.
    The 2013 document provides an in-depth analysis of the histopathological characteristics of scarring (cicatricial) and nonscarring (non-cicatricial) hair loss, emphasizing the importance of biopsy technique, hair cycle understanding, and clinical correlation for accurate diagnosis. It describes the optimal biopsy size and sectioning method, and differentiates between various hair loss conditions based on histological features. Cicatricial alopecias, such as lichen planopilaris and chronic cutaneous lupus erythematosus, show specific patterns of follicular destruction and scarring, while nonscarring alopecias, like androgenetic alopecia and telogen effluvium, are characterized by hair miniaturization and increased telogen hairs, respectively, without primary follicular destruction. The document also covers other hair loss disorders, including alopecia areata, trichotillomania, and psoriatic alopecia, detailing their unique histopathological findings. It stresses that despite overlapping features among different types of hair loss, accurate diagnosis can be achieved through careful histological examination combined with clinical information.
    Discuss this study in the Community →

    Research cited in this study

    13 / 13 results

    Related Community Posts Join

    6 / 459 results
      If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      in Research  830 upvotes 7 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community scarring alopecia awareness in this community

      in Chat  33 upvotes 2 years ago
      Lichen Planopilaris (LPP), a form of permanent hair loss, which can be mistaken for seborrheic dermatitis and is characterized by scalp itching, burning, redness, and dandruff. Treatment options discussed include steroidal creams, finasteride, minoxidil, and RU58841.

      community How is there still no consensus on Topical Dutasteride in 2024?

      in Finasteride/Dutasteride  147 upvotes 10 months ago
      The conversation expresses frustration over the lack of clear evidence regarding the effectiveness and systemic impact of topical Dutasteride for hair loss treatment, despite years of discussion. People are criticized for not conducting proper research and for providing contradictory anecdotal claims.

    Similar Research

    5 / 1000+ results
      Stem Cells and Alopecia: A Review of Pathogenesis

      research Stem Cells and Alopecia: A Review of Pathogenesis

      33 citations, April 2012 in “British Journal of Dermatology”
      Damaged hair follicle stem cells can cause permanent hair loss, but understanding their role could lead to new treatments.
      Proceedings of the Ninth World Congress for Hair Research 2015

      research Proceedings of the Ninth World Congress for Hair Research 2015

      January 2017 in “Journal of Investigative Dermatology Symposium Proceedings”
      The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.